Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Martin M. Meremikwu"" wg kryterium: Autor


Tytuł:
Patient-related factors and outcome of retinoblastoma in Calabar, Nigeria: A single-center, retrospective study
Autorzy:
Elizabeth D. Nkanga
Anthony C. Nlemadim
Mattan Arazi
Dennis G. Nkanga
Roseline E. Duke
Ido D. Fabian
Essemfon D. Nkanga
Friday A. Odey
Martin M. Meremikwu
Pokaż więcej
Temat:
Retinoblastoma
Patient factors
Clinical outcome
Survival
Treatment
Pediatrics
RJ1-570
Źródło:
Pediatric Hematology Oncology Journal, Vol 9, Iss 2, Pp 87-94 (2024)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S2468124524000196; https://doaj.org/toc/2468-1245
Dostęp URL:
https://doaj.org/article/ab2ec51fa1b54af492a2ee4feb41e610  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Multiple Plasmodium falciparum drug resistance polymorphisms identified in a pregnant woman with severe malaria and a concomitant spontaneous abortion in Cross River, Nigeria, West Africa
Autorzy:
Mary Aigbiremo Oboh
Fatou Faal
Oluwagbemisola Elizabeth Adeniji
Simon Correa
Anthony Uyimulam Amawu
Ekon Ogban
Eva Heinz
Grant Hughes
Martin M. Meremikwu
Alfred Amambua-Ngwa
Pokaż więcej
Temat:
Plasmodium falciparum
Severe malaria
Pregnant woman
Quinine
Single nucleotide polymorphism
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
Źródło:
Malaria Journal, Vol 21, Iss 1, Pp 1-5 (2022)
Opis pliku:
electronic resource
Relacje:
https://doaj.org/toc/1475-2875
Dostęp URL:
https://doaj.org/article/87edec9435464ab4a112eed160045fcd  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Evaluation of pulmonary tuberculosis case detection improvement with the deployment of XpertMTB/Rif in the tuberculosis control program of cross River State, Nigeria
Autorzy:
Ernest Afu Ochang
Ubleni E Emanghe
Atana Ewa
Akaninyene Otu
Jonah B Offor
Micheal Odo
Aniekan Etokidem
Barinadaa Afirima
Oju Eni Owuna
Sunday M Obeten
Martin M Meremikwu
Pokaż więcej
Temat:
Acid-fast bacilli
genexpert
smear microscopy
tuberculosis
Ziehl–Neelsen
Microbiology
QR1-502
Źródło:
International Journal of Mycobacteriology, Vol 6, Iss 1, Pp 94-96 (2017)
Opis pliku:
electronic resource
Relacje:
http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=1;spage=94;epage=96;aulast=Ochang; https://doaj.org/toc/2212-5531; https://doaj.org/toc/2212-554X
Dostęp URL:
https://doaj.org/article/7de53afda79b46d084028c700e6eba6b  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Comparison of cold water sponging and acetaminophen in control of fever among children attending a tertiary hospital in South Nigeria
Autorzy:
Tony M Aluka
Abraham N Gyuse
Ndifreke E Udonwa
Udeme E Asibong
Martin M Meremikwu
Angela Oyo-Ita
Pokaż więcej
Temat:
Children
cold water sponging
fever
paracetamol
temperature
Medicine
Źródło:
Journal of Family Medicine and Primary Care, Vol 2, Iss 2, Pp 153-158 (2013)
Opis pliku:
electronic resource
Relacje:
http://www.jfmpc.com/article.asp?issn=2249-4863;year=2013;volume=2;issue=2;spage=153;epage=158;aulast=Aluka; https://doaj.org/toc/2249-4863
Dostęp URL:
https://doaj.org/article/1bb924d8b7944be1b2e673ca4ca11719  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Evaluation of rifampicin resistance and 81-bp rifampicin resistant determinant region of rpoB gene mutations of Mycobacterium tuberculosis detected with XpertMTB/Rif in Cross River State, Nigeria
Autorzy:
Ernest A Ochang
Ubong A Udoh
Ubleni E Emanghe
Gerald O Tiku
Jonah B Offor
Micheal Odo
Emmanuel Nkombe
Oju E Owuna
Sunday M Obeten
Martin M Meremikwu
Pokaż więcej
Temat:
GeneXpert
Mycobacterium tuberculosis
rpoB gene
Tuberculosis
Microbiology
QR1-502
Źródło:
International Journal of Mycobacteriology, Vol 5, Iss 5, Pp 145-146 (2016)
Opis pliku:
electronic resource
Relacje:
http://www.ijmyco.org/article.asp?issn=2212-5531;year=2016;volume=5;issue=5;spage=145;epage=146;aulast=Ochang; https://doaj.org/toc/2212-5531; https://doaj.org/toc/2212-554X
Dostęp URL:
https://doaj.org/article/4355c714254a402e8f74c82520c8ce4a  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Newborn and child health national and provincial clinical practice guidelines in South Africa, Nigeria and Malawi: a scoping review.
Autorzy:
Mthethwa M; Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.
Mbeye NM; Evidence Informed Decision-Making Centre, Department of Community and Environmental Health, School of Global and Public Health, Kamuzu University of Health Sciences, Lilongwe, Malawi.
Effa E; Cochrane Nigeria, University of Calabar Teaching Hospital, Calabar, Nigeria.; Department of Internal Medicine, University of Calabar, Calabar, Nigeria.
Arikpo D; Cochrane Nigeria, University of Calabar Teaching Hospital, Calabar, Nigeria.
Blose N; Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.
Brand A; Centre for Evidence-Based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.
Chibuzor M; Cochrane Nigeria, University of Calabar Teaching Hospital, Calabar, Nigeria.
Chipojola R; Evidence Informed Decision-Making Centre, Department of Community and Environmental Health, School of Global and Public Health, Kamuzu University of Health Sciences, Lilongwe, Malawi.
Durao S; Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.
Esu E; Cochrane Nigeria, University of Calabar Teaching Hospital, Calabar, Nigeria.
Kallon II; Centre for Evidence-Based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.
Kunje G; Evidence Informed Decision-Making Centre, Department of Community and Environmental Health, School of Global and Public Health, Kamuzu University of Health Sciences, Lilongwe, Malawi.
Lakudzala S; Evidence Informed Decision-Making Centre, Department of Community and Environmental Health, School of Global and Public Health, Kamuzu University of Health Sciences, Lilongwe, Malawi.
Naude C; Centre for Evidence-Based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.
Leong TD; Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.
Lewin S; Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.; Department of Health Sciences Ålesund, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Mabetha D; Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.
McCaul M; Centre for Evidence-Based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.
Meremikwu M; Department of Paediatrics, University of Calabar, Calabar, Nigeria.
Vandvik PO; MAGIC Evidence Ecosystem Foundation, Oslo, Norway.; Department of Medicine, Lovisenberg Diaconal Hospital, Oslo, Norway.
Kredo T; Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa. .; Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. .
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2024 Feb 19; Vol. 24 (1), pp. 221. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Child Health*
Child ; Humans ; Infant, Newborn ; Malawi ; Nigeria ; South Africa ; Practice Guidelines as Topic
Czasopismo naukowe
Tytuł:
What makes knowledge translation work in practice? Lessons from a demand-driven and locally led project in Cameroon, Jordan and Nigeria.
Autorzy:
Borst RAJ; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O Box 1738, 3000DR, Rotterdam, the Netherlands. .
Wehrens R; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O Box 1738, 3000DR, Rotterdam, the Netherlands.
Nsangou M; Centre pour le Dévéloppement des Bonnes Pratiques en Santé, Yaoundé, Cameroon.
Arikpo D; Cochrane Nigeria, Institute of Tropical Diseases Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.
Esu E; Cochrane Nigeria, Institute of Tropical Diseases Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.; Department of Public Health, College of Medical Sciences, University of Calabar, Calabar, Nigeria.
Al Metleq A; The Higher Population Council, General Secretariat, Amman, Jordan.
Hobden O; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O Box 1738, 3000DR, Rotterdam, the Netherlands.
Meremikwu M; Cochrane Nigeria, Institute of Tropical Diseases Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.; Department of Paediatrics, University of Calabar Teaching Hospital, Calabar, Nigeria.
Ongolo-Zogo P; Centre pour le Dévéloppement des Bonnes Pratiques en Santé, Yaoundé, Cameroon.
Bal R; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O Box 1738, 3000DR, Rotterdam, the Netherlands.
Kok MO; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O Box 1738, 3000DR, Rotterdam, the Netherlands.
Pokaż więcej
Źródło:
Health research policy and systems [Health Res Policy Syst] 2023 Dec 04; Vol. 21 (1), pp. 127. Date of Electronic Publication: 2023 Dec 04.
Typ publikacji:
Journal Article
MeSH Terms:
Translational Science, Biomedical*
Translational Research, Biomedical*/methods
Humans ; Cameroon ; Jordan ; Nigeria
Czasopismo naukowe
Tytuł:
Predictors of Lassa fever diagnosis in suspected cases reporting to health facilities in Nigeria.
Autorzy:
Ochu CL; Department of Prevention Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Nigeria.
Ntoimo L; Department of Demography and Social Statistics, Faculty of Social Sciences, Federal University Oye-Ekiti, Oye-Ekiti, Nigeria.
Onoh I; Department of Health Emergency Preparedness and Response, Nigeria Centre for Disease Control, Abuja, Nigeria.
Okonofua F; Centre of Excellence in Reproductive Health Innovation, University of Benin, Benin City, Nigeria.
Meremikwu M; Cochrane Nigeria, Institute of Tropical Diseases Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.; Department of Paediatrics, University of Calabar Teaching Hospital, Calabar, Nigeria.
Mba S; Department of Surveillance and Epidemiology, Nigeria Centre for Disease Control, Abuja, Nigeria.
Iniobong A; Department of Health Emergency Preparedness and Response, Nigeria Centre for Disease Control, Abuja, Nigeria.
Nwafor O; Department of Surveillance and Epidemiology, Nigeria Centre for Disease Control, Abuja, Nigeria.
Dalhat M; Department of Prevention Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Nigeria.; Infectious Diseases Control Centre, Kaduna, Kaduna State, Nigeria.
Ohonsi C; Department of Prevention Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Nigeria.
Arinze C; Department of Surveillance and Epidemiology, Nigeria Centre for Disease Control, Abuja, Nigeria.
Esu E; Cochrane Nigeria, Institute of Tropical Diseases Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.; Department of Public Health, College of Medical Sciences, University of Calabar, Calabar, Nigeria.
Igumbor EU; Centre for Infectious Disease Research, Nigerian Institute of Medical Research, Lagos, Nigeria.
Dan-Nwafor C; Department of Surveillance and Epidemiology, Nigeria Centre for Disease Control, Abuja, Nigeria. .
Ilori E; Department of Surveillance and Epidemiology, Nigeria Centre for Disease Control, Abuja, Nigeria.
Adetifa I; The Office of the Director General, Nigeria Centre for Disease Control, Abuja, Nigeria.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Apr 21; Vol. 13 (1), pp. 6545. Date of Electronic Publication: 2023 Apr 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lassa Fever*/diagnosis
Lassa Fever*/epidemiology
Humans ; Male ; Female ; Adult ; Middle Aged ; Nigeria/epidemiology ; Logistic Models ; Multivariate Analysis ; Health Facilities
Czasopismo naukowe
Tytuł:
Plasmodium malariae structure and genetic diversity in sub-Saharan Africa determined from microsatellite variants and linked SNPs in orthologues of antimalarial resistance genes.
Autorzy:
Oriero EC; Medical Research Council Unit The Gambia at LSHTM, Fajara, Gambia. .
Demba MA; Medical Research Council Unit The Gambia at LSHTM, Fajara, Gambia.
Diop MF; Medical Research Council Unit The Gambia at LSHTM, Fajara, Gambia.
Ishengoma DS; National Institute for Medical Research, Dar es Salaam, United Republic of Tanzania.
Amenga-Etego LN; University of Ghana, Legon, Accra, Ghana.
Ghansah A; Noguchi Memorial Institute for Medical Research, Accra, Ghana.
Apinjoh T; University of Buea, Buea, Cameroon.
Issiaka S; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.; Centre National de Recherche Scientifique et Technologique, Ouagadougou, Burkina Faso.
Djimde A; University of Science, Techniques and Technology, Bamako, Mali.
D'Alessandro U; Medical Research Council Unit The Gambia at LSHTM, Fajara, Gambia.
Meremikwu M; University of Calabar Teaching Hospital, Calabar, Nigeria.
Amambua-Ngwa A; Medical Research Council Unit The Gambia at LSHTM, Fajara, Gambia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Dec 19; Vol. 12 (1), pp. 21881. Date of Electronic Publication: 2022 Dec 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Malaria*/parasitology
Plasmodium malariae*/genetics
Humans ; Africa South of the Sahara ; Antimalarials/therapeutic use ; Microsatellite Repeats ; Polymorphism, Single Nucleotide ; Drug Resistance/genetics
Czasopismo naukowe
Tytuł:
Trust, community health workers and delivery of intermittent preventive treatment of malaria in pregnancy: a comparative qualitative analysis of four sub-Saharan countries.
Autorzy:
Enguita-Fernàndez C; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Alonso Y; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Lusengi W; Bureau d'Étude et de Gestion de l'Information Statistique (BÉGIS), Kinshasa, DRC.
Mayembe A; Bureau d'Étude et de Gestion de l'Information Statistique (BÉGIS), Kinshasa, DRC.
Manun'Ebo MF; Bureau d'Étude et de Gestion de l'Information Statistique (BÉGIS), Kinshasa, DRC.
Ranaivontiavina S; Malagasy Associates for Numerical Information and Statistical Analysis (MANISA), Antananarivo, Madagascar.
Rasoamananjaranahary AM; Malagasy Associates for Numerical Information and Statistical Analysis (MANISA), Antananarivo, Madagascar.
Mucavele E; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Macete E; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Nwankwo O; Department of Community Medicine, University of Calabar, Calabar, Cross River State, Nigeria.
Meremikwu M; Cross River Health and Demographic Surveillance System, University of Calabar, Cross River State, Nigeria.
Roman E; Jhpiego, affiliate of Johns Hopkins University, Baltimore, Maryland, USA.
Pagnoni F; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Menéndez C; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP).
Munguambe K; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.; Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Pokaż więcej
Źródło:
Global public health [Glob Public Health] 2021 Dec; Vol. 16 (12), pp. 1889-1903. Date of Electronic Publication: 2020 Dec 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antimalarials*/therapeutic use
Malaria*/prevention & control
Community Health Workers ; Female ; Humans ; Mozambique ; Pregnancy ; Trust
Czasopismo naukowe
Tytuł:
Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in southern Nigeria.
Autorzy:
Oyo-Ita AE; Department of Community Medicine, College of Medical Sciences, University of Calabar, Calabar, Nigeria.; Effective Health Care Alliance Programme, Institute of Tropical Disease, Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.
Hanlon P; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Nwankwo O; Department of Community Medicine, College of Medical Sciences, University of Calabar, Calabar, Nigeria.
Bosch-Capblanch X; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Arikpo D; Effective Health Care Alliance Programme, Institute of Tropical Disease, Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.
Esu E; Effective Health Care Alliance Programme, Institute of Tropical Disease, Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.; Department of Public Health, College of Medical Sciences, University of Calabar, Calabar, Nigeria.
Auer C; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Meremikwu M; Effective Health Care Alliance Programme, Institute of Tropical Disease, Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.; Department of Paediatrics, College of Medical Sciences, University of Calabar, Calabar, Nigeria.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Sep 16; Vol. 16 (9), pp. e0257277. Date of Electronic Publication: 2021 Sep 16 (Print Publication: 2021).
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Religious Personnel*
Community Health Services/*organization & administration
Health Education/*organization & administration
Immunization Programs/*economics
Immunization Programs/*organization & administration
Measles/*economics
Measles/*prevention & control
Measles Vaccine/*economics
Child ; Cluster Analysis ; Cost-Benefit Analysis ; Humans ; Immunization ; Infant ; Infant, Newborn ; Leadership ; Nigeria/epidemiology ; Public Health ; Religion ; Vaccination
Czasopismo naukowe
Tytuł:
Effects of engaging communities in decision-making and action through traditional and religious leaders on vaccination coverage in Cross River State, Nigeria: A cluster-randomised control trial.
Autorzy:
Oyo-Ita A; Department of Community Medicine, Faculty of Medicine, College of Medical Sciences, University of Calabar, Calabar, Cross River State, Nigeria.; Effective Health Care Alliance Programme, Institute of Tropical Disease, Research and Prevention, University of Calabar Teaching Hospital, Calabar, Cross River State, Nigeria.
Bosch-Capblanch X; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland.
Ross A; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland.
Oku A; Department of Community Medicine, Faculty of Medicine, College of Medical Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Esu E; Effective Health Care Alliance Programme, Institute of Tropical Disease, Research and Prevention, University of Calabar Teaching Hospital, Calabar, Cross River State, Nigeria.; Department of Public Health, Faculty of Allied Medicine, College of Medical Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Ameh S; Department of Community Medicine, Faculty of Medicine, College of Medical Sciences, University of Calabar, Calabar, Cross River State, Nigeria.; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.
Oduwole O; Effective Health Care Alliance Programme, Institute of Tropical Disease, Research and Prevention, University of Calabar Teaching Hospital, Calabar, Cross River State, Nigeria.; Department of Medical Laboratory Science, Achievers University, Owo, Ondo State, Nigeria.
Arikpo D; Effective Health Care Alliance Programme, Institute of Tropical Disease, Research and Prevention, University of Calabar Teaching Hospital, Calabar, Cross River State, Nigeria.
Meremikwu M; Effective Health Care Alliance Programme, Institute of Tropical Disease, Research and Prevention, University of Calabar Teaching Hospital, Calabar, Cross River State, Nigeria.; Department of Paediatrics, Faculty of Medicine, College of Medical Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Apr 16; Vol. 16 (4), pp. e0248236. Date of Electronic Publication: 2021 Apr 16 (Print Publication: 2021).
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Public Health/*methods
Vaccination/*statistics & numerical data
Vaccination Coverage/*statistics & numerical data
Adult ; Female ; Health Education ; Humans ; Immunization Programs ; Infant ; Leadership ; Male ; Measles/prevention & control ; Measles Vaccine/therapeutic use ; Nigeria/epidemiology ; Parents/education ; Public Health/trends ; Religious Personnel/psychology ; Rural Population ; Vaccination Coverage/methods
Czasopismo naukowe
Tytuł:
Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria.
Autorzy:
Sowunmi A; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria. .; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria. .; Institute for Medical Research and Training, University of Ibadan, Ibadan, Nigeria. .; Department of Clinical Pharmacology, University College Hospital, Ibadan, Ibadan, Nigeria. .
Ntadom G; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.
Akano K; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.; Department of Biological Sciences and African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer University, Ede, Nigeria.
Ibironke FO; Department of Clinical Pharmacology, University College Hospital, Ibadan, Ibadan, Nigeria.
Ayede AI; Department of Paediatrics, University of Ibadan, Ibadan, Nigeria.
Agomo C; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Medical Laboratory Science, University of Lagos, Lagos, Nigeria.
Folarin OA; Department of Biological Sciences and African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer University, Ede, Nigeria.
Gbotosho GO; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.; Institute for Medical Research and Training, University of Ibadan, Ibadan, Nigeria.; Department of Pharmacology and Toxicology, University of Ibadan, Ibadan, Nigeria.
Happi C; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Biological Sciences and African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer University, Ede, Nigeria.
Oguche S; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Paediatrics, University of Jos, Jos, Nigeria.
Okafor HU; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Pediatrics, Institute of Child Health, University of Nigeria Teaching Hospital, Enugu, Nigeria.
Meremikwu M; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Paediatrics, University of Calabar, Calabar, Cross River State, Nigeria.
Agomo P; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Nigeria Institute of Medical Research, Lagos, Nigeria.
Ogala W; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Paediatrics, Ahmadu Bello University, Zaria, Nigeria.
Watila I; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Paediatrics, Specialist Hospital, Maiduguri, Nigeria.
Mokuolu O; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Paediatrics and Child Health, University of Ilorin, Ilorin, Nigeria.
Finomo F; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Paediatrics, Federal Medical Centre, Yenagoa, Nigeria.
Ebenebe JC; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Paediatrics, Nnamdi Azikiwe University, Awka, Nigeria.
Jiya N; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Paediatrics, Uthman Dan Fodio University, Sokoto, Nigeria.
Ambe J; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Paediatrics, University of Maiduguri, Maiduguri, Nigeria.
Wammanda R; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Paediatrics, Ahmadu Bello University, Zaria, Nigeria.
Emechebe G; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Paediatrics, Imo State University Teaching Hospital, Orlu, Nigeria.
Oyibo W; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Medical Microbiology and Parasitology, University of Lagos, Lagos, Nigeria.
Useh F; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; Department of Medical Laboratory Science, University of Calabar, Calabar, Nigeria.
Aderoyeje T; Department of Clinical Pharmacology, University College Hospital, Ibadan, Ibadan, Nigeria.
Dokunmu TM; Department of Biochemistry, Covenant University, Ota, Nigeria.
Alebiosu OT; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.
Amoo S; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.
Basorun OK; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.
Wewe OA; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.
Okafor C; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.
Akpoborie O; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.
Fatunmbi B; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.; World Health Organization, Country Office, Kampala, Uganda.
Adewoye EO; Department of Physiology, University of Ibadan, Ibadan, Nigeria.
Ezeigwe NM; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
Oduola A; University of Ibadan Research Foundation, University of Ibadan, Ibadan, Nigeria.
Pokaż więcej
Źródło:
Infectious diseases of poverty [Infect Dis Poverty] 2019 Aug 06; Vol. 8 (1), pp. 69. Date of Electronic Publication: 2019 Aug 06.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Resistance*
Antimalarials/*therapeutic use
Artemisinins/*therapeutic use
Malaria, Falciparum/*prevention & control
Plasmodium falciparum/*drug effects
Adolescent ; Amodiaquine/therapeutic use ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Child ; Child, Preschool ; Drug Combinations ; Female ; Humans ; Infant ; Male ; Nigeria
Czasopismo naukowe
Tytuł:
Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
Autorzy:
Esu E; Center for International Health (CIH), Ludwig-Maximilians-Universität (LMU), Leopoldstraße 7, 80802, Munich, Germany. .; Department of Public Health, College of Medical Sciences, University of Calabar, Calabar, Nigeria. .
Berens-Riha N; Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Leopoldstrasse 5, 80802, Munich, Germany.
Pritsch M; Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Leopoldstrasse 5, 80802, Munich, Germany.
Nwachuku N; Department of Public Health, College of Medical Sciences, University of Calabar, Calabar, Nigeria.
Loescher T; Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Leopoldstrasse 5, 80802, Munich, Germany.
Meremikwu M; Department of Paediatrics, College of Medical Sciences, University of Calabar, Calabar, Nigeria.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2018 Jul 06; Vol. 17 (1), pp. 251. Date of Electronic Publication: 2018 Jul 06.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Antimalarials/*therapeutic use
Artemether, Lumefantrine Drug Combination/*therapeutic use
Malaria, Falciparum/*prevention & control
Mass Screening/*statistics & numerical data
Parasitemia/*drug therapy
Pregnancy Complications, Parasitic/*prevention & control
Pyrimethamine/*therapeutic use
Sulfadoxine/*therapeutic use
Adolescent ; Adult ; Chemoprevention ; Drug Combinations ; Female ; Humans ; Incidence ; Malaria, Falciparum/parasitology ; Nigeria/epidemiology ; Parasitemia/parasitology ; Plasmodium falciparum/drug effects ; Plasmodium falciparum/physiology ; Pregnancy ; Prevalence ; Young Adult
Czasopismo naukowe
Tytuł:
Emergency transportation interventions for reducing adverse pregnancy outcomes in low- and middle-income countries: a systematic review protocol.
Autorzy:
Ehiri J; Department of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, University of Arizona, 1295 N. Martin Avenue, Tucson, AZ, 85724, USA. .
Alaofè H; Department of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, University of Arizona, 1295 N. Martin Avenue, Tucson, AZ, 85724, USA.
Asaolu I; Department of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, University of Arizona, 1295 N. Martin Avenue, Tucson, AZ, 85724, USA.
Chebet J; Department of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, University of Arizona, 1295 N. Martin Avenue, Tucson, AZ, 85724, USA.
Esu E; Department of Public Health, University of Calabar Teaching Hospital, Moore Road, Calabar, Cross River State, Nigeria.
Meremikwu M; Department of Public Health, University of Calabar Teaching Hospital, Moore Road, Calabar, Cross River State, Nigeria.
Pokaż więcej
Źródło:
Systematic reviews [Syst Rev] 2018 Apr 25; Vol. 7 (1), pp. 65. Date of Electronic Publication: 2018 Apr 25.
Typ publikacji:
Journal Article
MeSH Terms:
Emergency Medical Services*
Health Facilities*
Pregnancy Outcome*
Transportation*
Pregnancy Complications/*therapy
Delivery, Obstetric/methods ; Developing Countries ; Female ; Humans ; Infant ; Infant Mortality ; Pregnancy ; Systematic Reviews as Topic
Czasopismo naukowe
Tytuł:
Cochrane Africa: a network of evidence-informed health-care decision making across sub-saharan Africa.
Autorzy:
Mbuagbaw L; Centre for the Development of Best Practices in Health, Central Hospital, University of Yaoundé 1, Yaoundé, Cameroon.; Department of Health Research Methods, Evidence and Impact McMaster University, Hamilton, Canada.; Biostatistics Unit, Father Sean O'Sullivan Research Centre, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
Zogo PO; Centre for the Development of Best Practices in Health, Central Hospital, University of Yaoundé 1, Yaoundé, Cameroon.
Kredo T; Cochrane South Africa, South African Medical Research Council, Cape Town, Western Cape, South Africa.; Division of Clinical Pharmacology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Durao S; Cochrane South Africa, South African Medical Research Council, Cape Town, Western Cape, South Africa.
Young T; Cochrane South Africa, South African Medical Research Council, Cape Town, Western Cape, South Africa.; Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Effa E; Department of Medicine, University of Calabar, Calabar, Nigeria.; Cochrane Nigeria, Institute of Tropical Disease Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.
Meremikwu M; Cochrane Nigeria, Institute of Tropical Disease Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.; Department of Paediatrics, University of Calabar, Calabar, Nigeria.
Hohlfeld A; Cochrane South Africa, South African Medical Research Council, Cape Town, Western Cape, South Africa.
Wiysonge C; Cochrane South Africa, South African Medical Research Council, Cape Town, Western Cape, South Africa.
Pokaż więcej
Źródło:
The Pan African medical journal [Pan Afr Med J] 2018 Apr 03; Vol. 29, pp. 196. Date of Electronic Publication: 2018 Apr 03 (Print Publication: 2018).
Typ publikacji:
Journal Article
MeSH Terms:
Decision Making*
Delivery of Health Care/*organization & administration
Evidence-Based Medicine/*organization & administration
Africa South of the Sahara ; Capacity Building ; Humans ; Information Dissemination ; International Cooperation ; Translational Research, Biomedical
Czasopismo naukowe
Tytuł:
Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria -associated anaemia in Nigerian children during seven years of adoption as first-line treatments.
Autorzy:
Sowunmi A; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria. .; Institute for Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria. .; Department of Clinical Pharmacology, University College Hospital, Ibadan, Nigeria. .
Akano K; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.
Ntadom G; National Malaria Elimination Programme, Federal Ministry of Health, Abuja, Nigeria.
Ayede AI; Department of Paediatrics, University of Ibadan, Ibadan, Nigeria.
Ibironke FO; Department of Clinical Pharmacology, University College Hospital, Ibadan, Nigeria.
Aderoyeje T; Department of Clinical Pharmacology, University College Hospital, Ibadan, Nigeria.
Adewoye EO; Department of Physiology, University of Ibadan, Ibadan, Nigeria.
Fatunmbi B; World Health Organization, Regional Office for the Western Pacific, Khan Daun Penh, Phnom Penh, Cambodia.
Oguche S; Department of Paediatrics, University of Jos, Jos, Nigeria.
Okafor HU; Department of Paediatrics, Institute of Child Health, University of Nigeria Teaching Hospital, Enugu, Nigeria.
Watila I; Department of Paediatrics, Specialist Hospital, Maiduguri, Borno Sate, Nigeria.
Meremikwu M; Department of Paediatrics, University of Calabar, Calabar, Cross Rivers State, Nigeria.
Agomo P; Nigeria Institute of Medical Research, Yaba, Lagos, Nigeria.
Ogala W; Department of Paediatrics, Ahmadu Bello University, Zaria, Nigeria.
Agomo C; Nigeria Institute of Medical Research, Yaba, Lagos, Nigeria.
Folarin OA; Department of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.
Gbotosho GO; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.; Institute for Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Happi CT; Department of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.
Pokaż więcej
Źródło:
Infectious diseases of poverty [Infect Dis Poverty] 2017 Feb 07; Vol. 6 (1), pp. 36. Date of Electronic Publication: 2017 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Amodiaquine/*therapeutic use
Anemia/*pathology
Antimalarials/*therapeutic use
Artemisinins/*therapeutic use
Ethanolamines/*therapeutic use
Fluorenes/*therapeutic use
Malaria, Falciparum/*complications
Malaria, Falciparum/*drug therapy
Adolescent ; Artemether, Lumefantrine Drug Combination ; Child ; Child, Preschool ; Drug Combinations ; Female ; Hematocrit ; Humans ; Infant ; Male ; Nigeria ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).
Autorzy:
Tiono AB; Centre National de Recherche et de Formation sur le Paludisme, Ministère de la Santé, 01 BP 2208, Ouagadougou, Burkina Faso. .
Tinto H; Unité de Recherche Clinique de Nanoro (IRSS-CRUN), BP 218, Ouagadougou, CMS11, Burkina Faso. .
Alao MJ; Service de Pédiatrie, Hôpital de la Mère et de l'Enfant Lagune, Cotonou, 01 BP 107, Benin. .
Meremikwu M; Institute of Tropical Disease Research and Prevention, University of Calabar Teaching Hospital, Calabar, PMB 1278, Nigeria. .
Tshefu A; Kinshasa School of Public Health, University of Kinshasa, 11850, Kinshasa, Democratic Republic of Congo. .
Ogutu B; Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya. .
Ouedraogo A; Centre National de Recherche et de Formation sur le Paludisme, Ministère de la Santé, 01 BP 2208, Ouagadougou, Burkina Faso. .
Lingani M; Unité de Recherche Clinique de Nanoro (IRSS-CRUN), BP 218, Ouagadougou, CMS11, Burkina Faso. .
Cousin M; Novartis Pharma AG, CH-4002, Basel, Switzerland. .
Lefèvre G; Novartis Pharma AG, CH-4002, Basel, Switzerland. .
Jain JP; Novartis Healthcare Private Limited, Hyderabad, India. jay_.
Duparc S; Medicines for Malaria Venture (MMV), Route de Pré-Bois 20, 1215, Meyrin, Switzerland. .
Hamed K; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. .
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2015 Apr 15; Vol. 14, pp. 157. Date of Electronic Publication: 2015 Apr 15.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Antimalarials/*pharmacokinetics
Artemisinins/*pharmacokinetics
Ethanolamines/*pharmacokinetics
Fluorenes/*pharmacokinetics
Malaria, Falciparum/*drug therapy
Antimalarials/administration & dosage ; Antimalarials/adverse effects ; Artemether, Lumefantrine Drug Combination ; Artemisinins/administration & dosage ; Artemisinins/adverse effects ; Drug Combinations ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Ethanolamines/administration & dosage ; Ethanolamines/adverse effects ; Female ; Fluorenes/administration & dosage ; Fluorenes/adverse effects ; Humans ; Infant ; Male ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies